| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |